Merck Tells High Court FDA OK In Rejecting Fosamax Warning
Merck on Friday told the U.S. Supreme Court that the U.S. Food and Drug Administration rejected a proposed warning of femoral fractures for its osteoporosis drug Fosamax, but not because it...To view the full article, register now.
Already a subscriber? Click here to view full article